Gate Alpha 2nd Points Carnival Round 4 Hot Launch! Trade to Share $30,000 MORE & Alpha Points
Trade $MORE to unlock Listing Airdrops + $300K Points Prize Pool!
💰 Total Airdrop Volume: $30,000 MORE, Limited slots—first come, first served!
✅ Total Points: 2 Alpha Points per trade—accumulate points to share the $300K prize pool!
🔥Trade the Hottest On-Chain Assets First
For more information: https://www.gate.com/campaigns/1342alpha?pid=X&c=MemeBox&ch=vxDB0fQ5
Pioneer Pharma plans to acquire all shares of Conflux, and the two parties have signed a memorandum of understanding.
On July 1, Hong Kong listed company Pioneer Pharmaceutical Biotechnology (00399) announced that on June 30, 2025, the company (, as the buyer ), has signed a memorandum of understanding with the seller ( Northwestern Foundation ) and Conflux regarding the potential acquisition of all equity of the target company, contingent upon the target company completing the acquisition of Conflux assets according to the agreement with the company. Conflux is a limited company registered in Hong Kong, primarily engaged in the development of blockchain technology. The target company is a limited company that will be registered in the Cayman Islands and wholly owned by the seller. The company is actively exploring new business opportunities to diversify its revenue sources and implement strategic plans to enhance performance, as well as planning to expand its business into blockchain technology and enter the digital innovation industry. Signing the memorandum of understanding indicates the company's commitment to entering the digital innovation industry through potential acquisition activities to develop this new business division. The company believes that this move will not only diversify the group's business but also bring new profit growth momentum to the group.